370 related articles for article (PubMed ID: 10917002)
1. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V
Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of long-term bone metabolism in patients with relative hypoparathyroidism after changing the calcium concentration of the dialyzate to 3mEq/L].
Almirall J; Ponz E; López T; Trallero R; Valls R; Rodríguez A; Martínez JC; García M
Nefrologia; 2001; 21(5):485-92. PubMed ID: 11795018
[TBL] [Abstract][Full Text] [Related]
4. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R
Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
[TBL] [Abstract][Full Text] [Related]
5. Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis.
Holgado R; Haire H; Ross D; Sprague S; Pahl M; Jara A; Martin-Malo A; Rodriguez M; Almaden Y; Felsenfeld AJ
J Bone Miner Res; 2000 May; 15(5):927-35. PubMed ID: 10804023
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
7. Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study.
Lezaic V; Pejanovic S; Kostic S; Pljesa S; Dimkovic N; Komadina L; Jovanovic D; Marinkovic J; Djukanovic L
Ther Apher Dial; 2007 Apr; 11(2):121-30. PubMed ID: 17381533
[TBL] [Abstract][Full Text] [Related]
8. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.
Yano S; Sugimoto T; Tsukamoto T; Yamaguchi T; Hattori T; Sekita KI; Kaji H; Hattori S; Kobayashi A; Chihara K
Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
10. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
[TBL] [Abstract][Full Text] [Related]
11. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
Hwang JC; Chen CA; Wang CT; Chen HC
Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
[TBL] [Abstract][Full Text] [Related]
13. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
[TBL] [Abstract][Full Text] [Related]
14. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
15. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
Laway BA; Goswami R; Singh N; Gupta N; Seith A
Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
[TBL] [Abstract][Full Text] [Related]
16. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
18. Intravenous calcitriol can increase bone mass in hemodialysis patients with osteitis fibrosa.
Akiba T; Kurihara S; Yamada T; Ogasawara M; Yoneshima H; Marumo F
Miner Electrolyte Metab; 1995; 21(1-3):109-13. PubMed ID: 7565429
[TBL] [Abstract][Full Text] [Related]
19. Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study.
Bubenicek P; Sotornik I; Vitko S; Teplan V
Kidney Blood Press Res; 2008; 31(3):196-202. PubMed ID: 18535393
[TBL] [Abstract][Full Text] [Related]
20. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]